Find information on thousands of medical conditions and prescription drugs.

Zomig

Zolmitriptan is an oral, selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist, or triptan, for acute treatment of migraine attacks with or without aura. First launched in 1997, it is one of the second generation of triptan. It is available in tablet form, as a rapidly dissolving tablet that can be taken without water, and as a nasal spray.

People with migraines are often sensitive to artificial sweeteners, and should be aware that Zomg-ZMT (the dissolving tablet) contains aspartame, and hence conatin phenylalanine.

Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Greece & Argentina) and AscoTop (Germany).


 Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

Read more at Wikipedia.org
• [List your site here Free!]

MedPointe last month entered a marketing and distribution agreement with AstraZeneca for that company's Zomig family of prescription migraine triptan products
From Drug Store News, 10/20/03 by James Frederick

MedPointe last month entered a marketing and distribution agreement with AstraZeneca for that company's Zomig family of prescription migraine triptan products. Beginning Jan. 1, MedPointe will assume full responsibility for all Zomig sales and marketing in the United States.

U.S. net sales of Zomig totaled $177 million in 2002.

AstraZeneca will retain promotion rights outside the United States.

COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2003 Gale Group

Return to Zomig
Home Contact Resources Exchange Links ebay